Adiponectin and interleukin-6 levels in insulin-treated diabetic rats with experimental periodontitis

Brazilian Oral Research

Volumn 26, Issue 1, 2012, Pages 71-76

  Xynogala, Ioanna ^a   Pepelassi, Eudoxie ^a   Perrea, Despina ^b   Agrogiannis, George ^b   Pantopoulou, Alkistis ^b   Patsouris, Efstratios ^b   Vrotsos, Ioannis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adiponectin; Diabetes Mellitus; Insulin.; Periodontitis; Rats

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; INSULIN; INTERLEUKIN 6;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DIABETES MELLITUS; DISEASE MODEL; GLUCOSE BLOOD LEVEL; MALE; PERIODONTITIS; RANDOMIZATION; RAT; TIME; WISTAR RAT;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HYPOGLYCEMIC AGENTS; INSULIN; INTERLEUKIN-6; MALE; PERIODONTITIS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84861217439     PISSN: 18068324     EISSN: 18073107     Source Type: Journal    
DOI: 10.1590/S1806-83242012000100012     Document Type: Article

References (30)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Jan Care. 2011 34(Suppl 1):S62-69.
2. Lindhe J, Ranney R, Lamster I, Charles A, Chung CP, Flemmig T, et al. Consensus report: chronic periodontitis. Ann Periodontol. 1999 Dec;4(1):38.
3. Kinane D, Bouchard P. Periodontal diseases and health: consensus report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008 Sep;35(8 suppl):333-7.
4. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine. 2010 Feb;37(1):11-32.
5. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002 Jul;8(7):731-7.
6. Maahs DM, Ogden LG, Snell-Bergeon JK, Kinney GL, Wadwa RP, Hokanson JE, et al. Determinants of serum adiponectin in persons with and without type 1 diabetes. Am J Epidemiol. 2007 Sep 15;166(6):731-40.
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. ArteriosclerThromb Vasc Biol. 2000 Jun;20(6):1595-9.
8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83.
9. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone. 2004 Oct;35(4):842-9.
10. Shinoda Y, Yamaguchi M, Ogata N, Akune T, Kubota N, Yamauchi T, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem. 2006 Sep 1;99(1):196-208.
11. Williams GA, Wang Y, Callon KE, Watson M, Lin JM, Lam JB, et al. In vitro and in vivo effects of adiponectin on bone. Endocrinology. 2009 Aug;150(8):3603-10.
12. Yamaguchi N, Kukita T, Li YJ, Martinez Argueta JG, Saito T, Hanazawa S, et al. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol. 2007 Feb;49(1):28-34.
13. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res. 2006 Oct;21(10):1648-56.
14. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 Jul 18;286(3):327-34.
15. Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators Inflamm. 2006;2006(1):59206.
16. Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi Modulation of osteoclast differentiation by local factors. Bone. 1995 Aug;17(2 Suppl):87S-91S.
17. Verzeletti GN, Gaio EJ, Rösing CK. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats. Acta Odontol Scand. 2007 Nov;65(6):348-51.
18. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Relationship between periodontitis and diabetes: lessons from rodent studies. J Periodontol. 2007 Jul;78(7):1264-75.
19. Mishima N, Sahara N, Shirakawa M, Ozawa H. Effect of streptozotocin-induced diabetes mellitus on alveolar bone deposition in the rat. Arch Oral Biol. 2002 Dec;47(12):843-9.
20. Tesseromatis C, Kotsiou A, Parara H, Vairaktaris E, Tsamouri M. Morphological changes of gingiva in streptozotocin diabetic rats. Int J Dent. 2009;2009:725628. Epub 2009
21. Holzhausen M, Garcia DF, Pepato MT, Marcantonio E Jr. The influence of short-term diabetes mellitus and insulin therapy on alveolar bone loss in rats. J Periodontal Res. 2004 Jun;39(3):188-93.
22. Semenoff TA, Semenoff-Segundo A, Bosco AF, Nagata MJ, Garcia VG, Biasoli ER. Histometric analysis of ligatureinduced periodontitis in rats: a comparison of histological section planes. J Appl Oral Sci. 2008 Jul-Aug;16(4):251-6.
23. Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H, et al. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodontal Res. 2008 Oct;43(5):556-62.
24. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol. 2000 Oct;71(10):1528-34.
25. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003 Feb 21;301(4):1045-50.
26. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun. 2005 Jun 3;331(2):520-6.
27. Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res. 2008 Apr;87(4):319-22.
28. Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N, Yoshie H. The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol. 2010 Aug;81(8):1118-23.
29. Nagano Y, Arishiro K, Uene M, Miyake T, Kambara M, Notohara Y, et al. A low ratio of high molecular weight adiponectin to total adiponectin associates with periodontal status in middle-aged men. Biomarkers. 2011 Mar;16(2):106-11.
30. Yamaguchi N, Hamachi T, Kamio N, Akifusa S, Masuda K, Nakamura Y, et al. Expression levels of adiponectin receptors and periodontitis. J Periodontal Res. 2010 Apr;45(2):296-300.